NEW YORK, April 12, 2023 /PRNewswire/ -- The women's health therapeutics market size is forecast to increase by USD 30.35 billion from 2021 to 2026, at a CAGR of 5.74%, according to the recent market study by Technavio. The growth of the market will be driven by the strategic alliances, growing attention toward women's health, and an array of strong drug approvals. Technavio offers an up-to-date analysis of the current global market scenario and the overall market environment. View Sample Report.
Women's Health Therapeutics Market - Vendor Analysis:
The global women's health therapeutics market has several vendors with approved therapies. The treatment landscape for cancer is heavily dominated by surgery, leaving limited scope for therapeutics. Technavio has extensively analyzed 15 major vendors, including Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA
Get a holistic overview of the endoscopic closure devices market by industry experts to evaluate and develop growth strategies. Download the Sample
Vendor Offerings -
- Abbott Laboratories - The company offers women's health therapeutics such as Arachitol O, B Crip, Clome.
- AbbVie Inc. - The company offers women's health therapeutics such as Orilissa, Oriahnn.
- Amgen Inc. - The company offers women's health therapeutics such as Xgeva, Evenity.
- For more insights on vendors and their offerings, Request a Sample Report!
Key Benefits for Industry Players & Stakeholders –
- The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.
- It also provides detailed analyses of the market's competitive landscape and vendors' product offerings.
- The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
Expand operations in the future - To get requisite details, ask for a custom report.
Women's Health Therapeutics Market - Market Segmentation:
This report extensively covers women's health therapeutics market segmentation by type (fertility, oncology, menopause, infection, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)).
- The market share growth in the fertility segment will be significant for the market growth during the forecast period. There has been a decrease in the fertility rate in ROW over the years. The women's health therapeutics market is driven by the rise in the incidence of gynecological cancers in countries such as the US and Canada. For instance, it is estimated that around 14,100 women living in the US will be diagnosed with cervical cancer, and a further 4,280 women may die from cervical cancer in 2022 despite undergoing screening and treatment.
Charts & data tables about market and segment sizes for the forecast period (2022-2026) have been covered in this report. Download The Sample Report
Women's Health Therapeutics Market - Market Dynamics:
Key Drivers:
- A major driver fueling the growth of the women's health therapeutics market is strategic alliances.
- The global market witnessed multiple strategic alliances between vendors in recent years because the drug development process requires a highly advanced R&D team, which most mid-sized and small pharmaceutical vendors lack.
- Similarly, these small- and mid-sized pharmaceutical vendors have low profitability because they do not often achieve economies of scale. Also, the lack of an established distribution network globally poses a threat to some vendors, which limits their geographical presence in the market.
- This results in multiple vendors in the market entering into collaborative agreements to overcome the challenges associated with the research, manufacturing, and commercialization of drugs in new regions.
- Therefore, increasing alliances are expected to help in overcoming the research and commercialization challenges that currently exist.
- Hence, the growth in strategic alliances between vendors in the market is expected to drive the growth of the women's healthcare therapeutics market during the forecast period.
Major Trends:
- The availability of highly sensitive diagnostic modalities is an emerging trend influencing the women's health therapeutics market.
- Multiple organizations strive to raise awareness among people about gynecological diseases such as cancer, maternity disorders, and infectious diseases. For instance, the Centers for Disease Control and Prevention (CDC) conducts a campaign called Inside Knowledge: Get the Facts About Gynecologic Cancer, which provides the public with access to information about gynecological cancers.
- There are also worldwide events, such as Ovarian Cancer Awareness Month and Uterine Cancer Awareness Month, conducted in September, which aim to raise awareness about these diseases.
- Furthermore, some organizations work toward increasing patient awareness regarding all the major sub-types of gynecological disorders.
- Hence, the rising awareness of gynecological diseases is anticipated to drive the growth of the global women's therapeutics market during the forecast period.
Key Challenges:
- A key challenge hampering the growth of the women's health therapeutics market is the side effects of the approved drugs.
- Chemotherapy uses cytotoxic drugs to destroy cancer cells and hence, has harmful side effects. The cytotoxic drugs cannot distinguish between healthy and cancerous cells, due to which they also destroy the healthy peripheral cells that surround the cancer cells.
- The destruction of normal healthy cells leads to cytotoxic side effects and some of the most common side effects encountered with chemotherapy include alopecia, fatigue, myelosuppression, neurotoxicity, gastrointestinal toxicity, cutaneous reactions, reduced libido, and fertility problems.
- For instance, neutropenia is known to occur in patients, who are treated with certain cytotoxic drug regimens, and these patients require infusions of granulocyte colony-stimulating factors until the white blood cells have fully recovered.
- In order to avoid such harmful side effects, patients are opting for substitutes such as debulking surgery, thereby restricting the growth of the market.
- Hence, the serious side effects caused by the approved drugs are expected to impede the growth of the women's health therapeutics market during the forecast period.
To get detailed insights about Drivers, Trends, and Challenges, buy the report
What are the key data covered in this Women's Health Therapeutics Market report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the women's health therapeutics market between 2022 and 2026
- Precise estimation of the size of the women's health therapeutics market and its contribution to the market with a focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the women's health therapeutics market across North America, Europe, Asia, and Rest of World (ROW)
- A thorough analysis of the market's competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of women's health therapeutics market vendors
Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Related Reports:
- The global breast cancer therapeutics market size is estimated to grow by USD 13.85 billion between 2021 to 2026 accelerating at a CAGR of 8.95%. This breast cancer therapeutics market report extensively covers market segmentation by Product (targeted therapy, hormonal therapy, and chemotherapy) and Geography (North America, Europe, Asia, and Rest of World (ROW)). The rising number of patient support initiatives is the key factor driving the market growth.
- The alzheimer's disease therapeutics market is estimated to grow at a CAGR of 8.91% between 2022 and 2027. The size of the market is forecast to increase by USD 4,391.9 million. This report extensively covers market segmentation by drug class (cholinesterase inhibitors, n-methyl-d-aspartate receptor antagonist, and others), distribution channel (hospital pharmacy, retail pharmacy, and e-commerce pharmacy), and geography (North America, Europe, Asia, and Rest of World). The increasing awareness of alzheimer's disease notably drives the market growth.
Women's Health Therapeutics Market Scope |
|
Report Coverage |
Details |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.74% |
Market growth 2022-2026 |
USD 30.35 billion |
Market structure |
Fragmented |
YoY growth 2021-2022 (%) |
5.04 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Browse for Technavio's Health Care Market Reports
Key Topics Covered:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Fertility - Market size and forecast 2021-2026
- Exhibit 28: Chart on Fertility - Market size and forecast 2021-2026 ($ billion)
- Exhibit 29: Data Table on Fertility - Market size and forecast 2021-2026 ($ billion)
- Exhibit 30: Chart on Fertility - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Fertility - Year-over-year growth 2021-2026 (%)
- 5.4 Oncology - Market size and forecast 2021-2026
- Exhibit 32: Chart on Oncology - Market size and forecast 2021-2026 ($ billion)
- Exhibit 33: Data Table on Oncology - Market size and forecast 2021-2026 ($ billion)
- Exhibit 34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
- 5.5 Menopause - Market size and forecast 2021-2026
- Exhibit 36: Chart on Menopause - Market size and forecast 2021-2026 ($ billion)
- Exhibit 37: Data Table on Menopause - Market size and forecast 2021-2026 ($ billion)
- Exhibit 38: Chart on Menopause - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Menopause - Year-over-year growth 2021-2026 (%)
- 5.6 Infection - Market size and forecast 2021-2026
- Exhibit 40: Chart on Infection - Market size and forecast 2021-2026 ($ billion)
- Exhibit 41: Data Table on Infection - Market size and forecast 2021-2026 ($ billion)
- Exhibit 42: Chart on Infection - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Infection - Year-over-year growth 2021-2026 (%)
- 5.7 Others - Market size and forecast 2021-2026
- Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
- Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
- Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
- 5.8 Market opportunity by Type
- Exhibit 48: Market opportunity by Type ($ billion)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 50: Chart on Market share by geography 2021-2026 (%)
- Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 52: Chart on Geographic comparison
- Exhibit 53: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
- Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
- Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
- Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
- Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
- Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
- Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
- Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
- Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
- Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
- Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
- Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
- Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
- Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
- Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 China - Market size and forecast 2021-2026
- Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
- Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
- Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
- Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
- Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 90: Market opportunity by geography ($ billion)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 91: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 93: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 94: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 95: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 96: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 97: Abbott Laboratories - Overview
- Exhibit 98: Abbott Laboratories - Business segments
- Exhibit 99: Abbott Laboratories - Key news
- Exhibit 100: Abbott Laboratories - Key offerings
- Exhibit 101: Abbott Laboratories - Segment focus
- 10.4 AbbVie Inc.
- Exhibit 102: AbbVie Inc. - Overview
- Exhibit 103: AbbVie Inc. - Product / Service
- Exhibit 104: AbbVie Inc. - Key offerings
- 10.5 Amgen Inc.
- Exhibit 105: Amgen Inc. - Overview
- Exhibit 106: Amgen Inc. - Product / Service
- Exhibit 107: Amgen Inc. - Key offerings
- 10.6 Bayer AG
- Exhibit 108: Bayer AG - Overview
- Exhibit 109: Bayer AG - Business segments
- Exhibit 110: Bayer AG - Key offerings
- Exhibit 111: Bayer AG - Segment focus
- 10.7 Eli Lilly and Co.
- Exhibit 112: Eli Lilly and Co. - Overview
- Exhibit 113: Eli Lilly and Co. - Product / Service
- Exhibit 114: Eli Lilly and Co. - Key offerings
- 10.8 F. Hoffmann La Roche Ltd.
- Exhibit 115: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 116: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 117: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 118: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 119: F. Hoffmann La Roche Ltd. - Segment focus
- 10.9 ICON plc
- Exhibit 120: ICON plc - Overview
- Exhibit 121: ICON plc - Product / Service
- Exhibit 122: ICON plc - Key offerings
- 10.10 Merck KGaA
- Exhibit 123: Merck KGaA - Overview
- Exhibit 124: Merck KGaA - Business segments
- Exhibit 125: Merck KGaA - Key news
- Exhibit 126: Merck KGaA - Key offerings
- Exhibit 127: Merck KGaA - Segment focus
- 10.11 Mithra Pharmaceuticals SA
- Exhibit 128: Mithra Pharmaceuticals SA - Overview
- Exhibit 129: Mithra Pharmaceuticals SA - Product / Service
- Exhibit 130: Mithra Pharmaceuticals SA - Key offerings
- 10.12 Novartis AG
- Exhibit 131: Novartis AG - Overview
- Exhibit 132: Novartis AG - Business segments
- Exhibit 133: Novartis AG - Key offerings
- Exhibit 134: Novartis AG - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 135: Inclusions checklist
- Exhibit 136: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 137: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 138: Research methodology
- Exhibit 139: Validation techniques employed for market sizing
- Exhibit 140: Information sources
- 11.5 List of abbreviations
- Exhibit 141: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article